Quanterix

Quanterix Corporation is a life sciences company specializing in ultra-sensitive single-molecule analysis to enhance clinical diagnostics, drug development, and life science research. The company's innovative Simoa platform enables the rapid quantification of individual proteins and small molecules in complex biological samples, allowing for the detection of protein biomarkers at concentrations that conventional immunoassay technologies cannot identify. This capability addresses various unmet medical needs by facilitating earlier disease detection, improved prognostics, and more precise treatment methods. Quanterix's solutions, including assay kits and automated detection systems, aim to transform healthcare by providing researchers with critical insights into the role of biomarkers in health and disease. Founded in 2007, Quanterix is supported by prominent life science investors.